Project Grant AID674F1600001

This $582,959 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to integrate a "Universal Test-and-Connect" (UTC) strategy for HIV prevention and treatment services into two high-volume emergency department (ED) settings in Cape Town, South Africa. The 3-year project, running from September 2024 to September 2027, has three key objectives: Integrate HIV assessment into...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $1,272,602 to Trustees of Boston University and its sub-awardee Wits Health Consortium to conduct a cluster-randomized efficacy trial integrating the "Undetectable = Untransmittable" (U=U) messaging into HIV counseling in South Africa. The study aims to (1) refine a U=U educational mobile app intervention and (2) evaluate its impact on...

The National Center for HIV/AIDS awarded a $1,200,000 Cooperative Agreement to Matthew 25 AIDS Services, Inc. under the HIV Prevention Activities Health Department Based program (CFDA 93.940). This five-year project aims to enhance sexual health in rural Kentucky by accelerating clinical testing, prevention, and care for sexually transmitted infections (STIs), establishing a mobile sexual health clinic, and collaborating with community partners to deliver effective prevention, care, and...

This $300,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program supports the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project implemented by Humana People To People Congo (HPP-Congo) in Kinshasa, Democratic Republic of the Congo. The project aims to strengthen systematic, people-centered approaches to HIV/TB prevention, detection, and treatment, while improving clinical and community-based services...

This $1,325,208 Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to identify effective strategies for returning individuals living with HIV in Zambia to care and keeping them engaged after treatment lapses. The primary goals are to: 1) assess the effectiveness of outreach strategies, including navigation services and community-based medication delivery, to rapidly re-initiate ART and...

The Department of State Bureau of African Affairs awarded a $110,000 project grant to Treatment Advocacy And Litera CY Campaign to implement the COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK project from March 1, 2022 to December 30, 2022. Under this award, Treatment Advocacy And Litera CY Campaign will work to improve HIV care quality in Zambia by establishing a community-led monitoring program that gathers client feedback. The grant is part of the...

This federal Project Grant award of $1,935,300.00 from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will fund a site-randomized trial of a novel social network recruitment intervention called E-SNRHT in South Africa. The goal is to locate more undiagnosed HIV-positive cases, increase HIV testing among men, and reduce HIV-related stigma. The University of Illinois is the prime awardee and will collaborate with sub-awardees the Human Sciences Research...

This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to implement an innovative HIV self-testing and long-acting injectable HIV treatment and prevention intervention for commercial minibus drivers in Nigeria. The $809,692 award to The George Washington University, with sub-awards to Wake Forest University Health Sciences, University of Rochester, Emory...

This $5,900,000.00 Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), supports comprehensive efforts to combat HIV/AIDS globally through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The award to the National Health Laboratory Service (NHLS), a prominent non-profit organization based in South Africa, will fund a range of technical assistance, service delivery, and capacity-building activities over...